Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, rand...

Por Ascher, B, Hoffmann, K, Walker, P, Lippert, S, Wollina, U, Havlickova, B
Publicado no J Eur Acad Dermatol Venereol (2014)

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study

Por Layton, A.M., Schaller, M., Homey, B., Hofmann, M.A., Bewley, A.P., Lehmann, P., Nohlgård, C., Sarwer, D.B., Kerrouche, N., Ma, Y.M.
Publicado no J Eur Acad Dermatol Venereol (2015)

Effect of tofacitinib withdrawal and re‐treatment on patient‐reported outcomes: results from a Phase 3 study in patients with moderate to severe chronic plaque psoriasis

Por Griffiths, C.E.M., Vender, R., Sofen, H., Kircik, L., Tan, H., Rottinghaus, S.T., Bachinsky, M., Mallbris, L., Mamolo, C.
Publicado no J Eur Acad Dermatol Venereol (2016)